Keiretsu Forum has entered into a resource partnership with California University of Pennsylvania ("CalU"). The objective of this partnership is to further innovation, entrepreneurship, and technology transfer in the Mid-Atlantic region.

Carmell Therapeutics was elected as the Stephen M Goodman Most Valued Company at the 6th Annual Keiretsu Forum Mid-Atlantic and South-East Angel Capital Expo. Carmel Therapeutics will accept the award at Pittsburgh Chapter meeting on Friday.